Propranolol May Reduce Overall Stroke Risk in Women With Migraine
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 31, 2025 -- Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke, according to a study presented at the annual American Stroke Association International Stroke Conference, held from Feb. 5 to 7 in Los Angeles.
Mulubrhan Mogos, Ph.D., from the Vanderbilt University School of Nursing in Nashville, Tennessee, and colleagues conducted a retrospective case-control study to examine the role of propranolol in reducing stroke risk among patients with migraine. A total of 378 stroke cases (patients with a primary diagnosis of stroke after the first onset of migraine) and 15,209 controls (patients with no stroke diagnosis after the first onset of migraine) were identified from the Synthetic Derivative (SD) at Vanderbilt University Medical Center, while 267 cases and 6,579 controls were included from the All of Us database.
The researchers found that in female patients with migraine, propranolol was significantly associated with a reduced risk for overall stroke (odds ratios, 0.52 in SD and 0.39 in All of Us), but this association was not seen in male patients. A more pronounced protective effect was seen for ischemic stroke and in women with migraine without aura. Cumulative incidence analyses showed lower stroke rates at multiple time points.
"Many women suffer from migraines, and it's important to note that propranolol may be beneficial for these women, particularly those who experience migraine without aura," Mogos said in a statement. "This is an important discovery for those dealing with migraines."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI
FRIDAY, June 6, 2025 -- For patients who undergo percutaneous coronary intervention (PCI) and discontinue dual antiplatelet therapy (DAPT), P2Y12 inhibitor monotherapy is...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.